Herbal-drug interaction induced rhabdomyolysis in a liposarcoma patient receiving trabectedin

Por Strippoli, Sabino, Lorusso, Vito, Albano, Anna, Guida, Michele
Publicado em 2013

Basal cytokines profile in metastatic renal cell carcinoma patients treated with subcutaneous IL-2-based therapy compared with that of healthy donors

Por Guida, Michele, Casamassima, Addolorata, Monticelli, Giulia, Quaranta, Michele, Colucci, Giuseppe
Publicado em 2007

Long-term response of gemcitabine plus docetaxel chemotherapy regimen for extraskeletal osteosarcoma: A case report

Por STRIPPOLI, SABINO, TRAVERSA, MICHELE, CRAMAROSSA, ANTONIO, POPESCU, ONDINA, LORUSSO, VITO, GUIDA, MICHELE
Publicado no Oncol Lett (2015)

High activity of sequential low dose chemo-modulating Temozolomide in combination with Fotemustine in metastatic melanoma. A feasibility study

Por Guida, Michele, Cramarossa, Antonio, Fistola, Ettore, Porcelli, Mariangela, Giudice, Giuseppe, Lubello, Katia, Colucci, Giuseppe
Publicado em 2010

Is immunohistochemistry of BRAF V600E useful as a screening tool and during progression disease of melanoma patients?

Por Schirosi, Laura, Strippoli, Sabino, Gaudio, Francesca, Graziano, Giusi, Popescu, Ondina, Guida, Michele, Simone, Giovanni, Mangia, Anita
Publicado no BMC Cancer (2016)

microRNAs and next generation sequencing for the prognosis of the metastatic melanoma

Por Pinto, Rosamaria, De Summa, Simona, Strippoli, Sabino, Guida, Gabriella, Popescu, Ondina, Azzariti, Amalia, Guida, Michele, Tommasi, Stefania
Publicado no J Transl Med (2015)

The next generation of metastatic melanoma: uncovering the genetic variants for anti-BRAF therapy response

Por Pinto, Rosamaria, De Summa, Simona, Strippoli, Sabino, Pilato, Brunella, Azzariti, Amalia, Guida, Gabriella, Guida, Michele, Tommasi, Stefania
Publicado no Oncotarget (2016)

Proteomic Profile and In Silico Analysis in Metastatic Melanoma with and without BRAF Mutation

Por Garrisi, Vito Michele, Strippoli, Sabino, De Summa, Simona, Pinto, Rosamaria, Perrone, Antonella, Guida, Gabriella, Azzariti, Amalia, Guida, Michele, Stefania, Tommasi
Publicado no PLoS One (2014)

αβ-Double Negative CD4/CD8 (CD56) T cell (DNTs) in metastatic melanoma: basal frequency and behaviour during Ipilimumab treatment. Preliminary evaluations

Por De Tullio, Giacoma, Strippoli, Sabino, Angarano, Rosa, De Fazio, Vincenza, Sgherza, Nicola, Negri, Antonio, Albano, Anna, Iacopino, Pasquale, Guarini, Attilio, Guida, Michele
Publicado no J Transl Med (2015)

Fibrinogen: a novel predictor of responsiveness in metastatic melanoma patients treated with bio-chemotherapy: IMI (italian melanoma inter-group) trial

Por Guida, Michele, Ravaioli, Alessandra, Sileni, Vanna Chiarion, Romanini, Antonella, Labianca, Roberto, Freschi, Antonio, Brugnara, Salvatore, Casamassima, Addolorata, Lorusso, Vito, Nanni, Oriana, Ridolfi, Ruggero
Publicado em 2003

A prospective phase II trial exploring the association between tumor microenvironment biomarkers and clinical activity of ipilimumab in advanced melanoma

Por Hamid, Omid, Schmidt, Henrik, Nissan, Aviram, Ridolfi, Laura, Aamdal, Steinar, Hansson, Johan, Guida, Michele, Hyams, David M, Gómez, Henry, Bastholt, Lars, Chasalow, Scott D, Berman, David
Publicado em 2011

Tolerability of intensified intravenous interferon alfa-2b versus the ECOG 1684 schedule as adjuvant therapy for stage III melanoma: a randomized phase III Italian Melanoma Inter-g...

Por Chiarion-Sileni, Vanna, Del Bianco, Paola, Romanini, Antonella, Guida, Michele, Paccagnella, Adriano, Dalla Palma, Maurizio, Naglieri, Emanuele, Ridolfi, Ruggero, Silvestri, Barbara, Michiara, Maria, De Salvo, Gian Luca
Publicado em 2006

Barasertib: a novel approach for the treatment of metastatic melanoma

Por Azzariti, Amalia, Porcelli, Letizia, Quatrale, Anna Elisa, Sidella, Letizia, Iacobazzi, RM, Guida, Gabriella, Maida, Immacolata, Cocco, Tiziana, Ferretta, Anna, Strippoli, Sabino, Giuda, Stefania, Tommasi, Stefani, Paradiso, Angelo, Guida, Michele
Publicado em 2014

Aurora kinase B inhibition reduces the proliferation of metastatic melanoma cells and enhances the response to chemotherapy

Por Porcelli, Letizia, Guida, Gabriella, Quatrale, Anna E, Cocco, Tiziana, Sidella, Letizia, Maida, Immacolata, Iacobazzi, Rosa M, Ferretta, Anna, Stolfa, Diana A, Strippoli, Sabino, Guida, Stefania, Tommasi, Stefania, Guida, Michele, Azzariti, Amalia
Publicado no J Transl Med (2015)

The relevance of BRAF G469A mutation in determining the response to therapy in metastatic melanoma

Por Porcelli, Letizia, Guida, Gabriella, Cocco, Tiziana, Quatrale, Anna E, Iacobazzi, Rosa M, Stolfa, Diana A, Maida, Imma, Ferretta, Anna, Grieco, Claudia, Guida, Stefania, Strippoli, Sabino, Tommasi, Stefania, Guida, Michele, Azzariti, Amalia
Publicado no J Transl Med (2015)

The mitochondrial master regulator gene PGC1alpha in novel sporadic melanoma cell lines: correlations with BRAF mutational status

Por Guida, Gabriella, Maida, Immacolata, Ferretta, Anna, Cocco, Tiziana, Guida, Stefania, Zanna, Paola, Labarile, Rossella, Porcelli, Letizia, Azzariti, Amalia, Tommasi, Stefania, Albano, Anna, Strippoli, Sabino, Turpin Sevilla, Mari C, Filotico, Raffaele, Guida, Michele
Publicado em 2014

The cost of unresectable stage III or stage IV melanoma in Italy

Por Maio Michele, Ascierto Paolo, Testori Alessandro, Ridolfi Ruggero, Bajetta Emilio, Queirolo Paola, Guida Michele, Romanini Antonella, Chiarion-Sileni Vanna, Pigozzo Jacopo, Di Giacomo Anna Maria, Calandriello Mario, Didoni Guido, van Baardewijk Marck, Konto Cyril, Lucioni Carlo
Publicado em 2012-11-01

The cost of unresectable stage III or stage IV melanoma in Italy

Por Maio, Michele, Ascierto, Paolo, Testori, Alessandro, Ridolfi, Ruggero, Bajetta, Emilio, Queirolo, Paola, Guida, Michele, Romanini, Antonella, Chiarion-Sileni, Vanna, Pigozzo, Jacopo, Di Giacomo, Anna Maria, Calandriello, Mario, Didoni, Guido, van Baardewijk, Marck, Konto, Cyril, Lucioni, Carlo
Publicado em 2012

Efficacy and safety of ipilimumab in patients with advanced melanoma and brain metastases

Por Queirolo, Paola, Spagnolo, Francesco, Ascierto, Paolo Antonio, Simeone, Ester, Marchetti, Paolo, Scoppola, Alessandro, Del Vecchio, Michele, Di Guardo, Lorenza, Maio, Michele, Di Giacomo, Anna Maria, Antonuzzo, Andrea, Cognetti, Francesco, Ferraresi, Virginia, Ridolfi, Laura, Guidoboni, Massimo, Guida, Michele, Pigozzo, Jacopo, Chiarion Sileni, Vanna
Publicado em 2014

Clinical experience with ipilimumab 3 mg/kg: real-world efficacy and safety data from an expanded access programme cohort

Por Ascierto, Paolo A, Simeone, Ester, Sileni, Vanna Chiarion, Pigozzo, Jacopo, Maio, Michele, Altomonte, Maresa, Del Vecchio, Michele, Di Guardo, Lorenza, Marchetti, Paolo, Ridolfi, Ruggero, Cognetti, Francesco, Testori, Alessandro, Bernengo, Maria Grazia, Guida, Michele, Marconcini, Riccardo, Mandalà, Mario, Cimminiello, Carolina, Rinaldi, Gaetana, Aglietta, Massimo, Queirolo, Paola
Publicado em 2014